Paid Clinical Trials in Syracuse, NY
As of August 2026, 179 paid clinical trials are recruiting in Syracuse, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Syracuse offers studies at sites including State University of New York Upstate Medical University for conditions such as Acute Myeloid Leukemia, Speech Sound Disorder, Alzheimer Disease, Obesity. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Syracuse
Trials by drug in Syracuse
Filter results
Newly added in Syracuse
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
171 clinical trials
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Pompe Disease Registry Protocol
Fabry Disease Registry & Pregnancy Sub-registry
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Strategy for Improving Stroke Treatment Response
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
[18F]PI-2620 Phase 3 Histopathological Study
Top Research Study Locations in Syracuse
Researchers run research studies in Syracuse, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| State University of New York Upstate Medical University | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Acute Myeloid Leukemia Post Cytotoxic Therapy | 53 |
| SUNY Upstate Medical University | NMIBC, Alzheimer Disease, Alzheimer's Disease | 36 |
| SUNY Upstate Medical Center-Community Campus | Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Advanced Lung Non-Small Cell Carcinoma | 9 |
| Syracuse University | Speech Sound Disorder, Alcohol Drinking, Aphasia Following Cerebral Infarction | 8 |
| Syracuse VA Medical Center, Syracuse, NY | Spinal Cord Injury, Depression, Emergency Service | 7 |
| Upstate Cancer Center at Hill Radiation Oncology | Endometrial Cancer, Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma | 5 |
| Associated Med Professionals of NY | Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer, Oligometastatic Prostate Cancer (OMPC) | 4 |
| Ichor Research | Alzheimer Disease, Aggression, Agitation,Psychomotor | 4 |
| SUNY Upstate | Carcinoma, Transitional Cell, Head and Neck Cancer, High-Risk Non-Muscle-Invasive Bladder Cancer | 4 |
| Associated Medical Professionals of NY | FGFR Gene Alterations, FGFR Gene Amplification, FGFR3 Gene Alteration | 3 |
| Associated Medical Professionals | Non-Muscle Invasive Bladder Neoplasms | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| Nkarta Investigational Site | Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, Idiopathic Inflammatory Myopathies, Lupus Nephritis | 2 |
| Upstate Golisano Children's Hospital | COVID-19, Cardiac Arrest, Cardiopulmonary Arrest | 2 |
| Associated Medical Professionals - Urology | Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms | 2 |
| SUNY Upstate Cancer Center | Carcinoma, Non-Small-Cell Lung, Lymphoma, Large B-Cell, Diffuse | 2 |
| SUNY Upstate Medical University - Syracuse | Ovarian Cancer, Type 1 Diabetes | 2 |
| State University of New York | Endometrial Cancer, Cerebroside Lipidosis Syndrome, Gaucher Disease | 2 |
| Altimmune Clinical Study Site | Alcohol Liver Disease | 1 |
| Associated Medical Professionals of NY, PLLC | Low Grade Upper Tract Urothelial Carcinoma | 1 |
| Associated Medical Professionals of NY, PLLC (US Urology Partners) | High-Risk Non-Muscle-Invasive Bladder Cancer | 1 |
| Crouse Health System and Crouse Medical Practice | Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Ventricular Arrhythmia | 1 |
| Crouse Physicians Office Building | COVID-19 | 1 |
| Exelixis Clinical | Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 1 |
| Golisano Center for Special Needs | Autism Spectrum Disorder | 1 |
Active & Upcoming Studies in Syracuse (2026)
Recruiting trials in Syracuse grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (74 active studies)
- A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · Phase 1 · UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
Neurology & pain (14 active studies)
- A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS) · Phase 2 · Hoffmann-La Roche
- Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia · Syracuse University
Diabetes & metabolic (11 active studies)
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes · Phase 3 · Eli Lilly and Company
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
Cardiovascular (7 active studies)
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure · Boston Scientific Corporation
- Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease · Phase 3 · Alessandro Doria
Mental health & behavior (3 active studies)
- Self-Help Intervention for Post 9/11 Veterans With Depression or PTSD Symptoms · VA Office of Research and Development
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
Vaccines (2 active studies)
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
- EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease · Phase 3 · Pfizer
HIV / STI (2 active studies)
- Health-E You Efficacy Trial for Male Adolescents · Johns Hopkins University
- Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers · Syracuse University
Pediatric (1 active study)
- Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy · Massachusetts General Hospital
Common conditions studied in Syracuse
- Acute Myeloid Leukemia (5 active studies)
- Speech Sound Disorder (5 active studies)
- Alzheimer Disease (4 active studies)
- Obesity (4 active studies)
- Stage IV Lung Cancer AJCC v8 (4 active studies)
- Acute Myeloid Leukemia Post Cytotoxic Therapy (3 active studies)
Leading research sponsors in Syracuse
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- Syracuse University
- VA Office of Research and Development
Frequently asked questions
How many paid clinical trials are currently recruiting in Syracuse?
There are approximately 179 recruiting clinical trials in Syracuse, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Syracuse pay participants?
Most recruiting trials in Syracuse compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Syracuse?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Syracuse?
The most common conditions under active study in Syracuse include Acute Myeloid Leukemia (5), Speech Sound Disorder (5), Alzheimer Disease (4), Obesity (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Syracuse?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Syracuse on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Syracuse?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Syracuse?
Recruiting research sites in Syracuse include State University of New York Upstate Medical University, SUNY Upstate Medical University, SUNY Upstate Medical Center-Community Campus, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Syracuse right now?
The largest active categories in Syracuse are Cancer & tumors (74), Neurology & pain (14), Diabetes & metabolic (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.